// App-Quantinova.ai

: Impact of bone metastasis on clinical outcomes in metastatic urothelial bladder cancer (mUC) for patients treated with first-line platinum-based chemotherapy.

Researchers

Presenter

  • Jamila Jama Almi Riromar

Principal Investigators

  • Zachary William Neil Veitch

  • Adrian G. Sacher

  • Manjula Maganti

  • Nazanin Fallah-Rad

  • Aaron Richard Hansen

  • Srikala S. Sridhar

Medical Centers

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • Dana-Farber Cancer Institute, Boston, MA

  • Princess Margaret Hospital, Toronto, ON, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bone metastases

  • Bladder Cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A